📊 Evidence-Based Reference

1 8mm x 149 cm phoenix atherectomy catheter 2 2mm x 149 cm phoenix atherectomy catheter phoenix handle phoenix wire support clip

Volcano Atheromed

Summary: The Phoenix Atherectomy Catheter is a device used for atherectomy procedures, primarily to remove plaque from blood vessels. Key evidence includes FDA clearance and linked studies on imaging techniques.

FDA Clearance Information

Pathway 510K
Decision Date December 19, 2014
Product Code MCW
Device Class Class 2
Evidence 8 studies

The Phoenix Atherectomy Catheter was cleared by the FDA via the 510(k) pathway on December 19, 2014. It is manufactured by Volcano Atheromed and classified as a Class 2 device.

What It Is

The Phoenix Atherectomy Catheter is designed for atherectomy, a procedure to remove atherosclerotic plaque from blood vessels. It is used to improve blood flow in patients with peripheral artery disease.

Clinical Applications

Commonly used in interventional cardiology and vascular surgery, the Phoenix Atherectomy Catheter is employed in scenarios requiring plaque removal to restore vessel patency and improve circulation.

Evidence Summary

The available literature includes three studies, primarily retrospective and survey-based, spanning from 1998 to 2007. These studies focus on imaging techniques relevant to device application.

Reported Outcomes

Published studies report on the efficacy of imaging techniques in detecting conditions relevant to the use of atherectomy devices. However, specific outcomes related to the Phoenix Atherectomy Catheter itself are not detailed in the provided evidence.

Safety Profile

Reported complications include general risks associated with imaging and interventional procedures, but specific safety data for the Phoenix Atherectomy Catheter is not detailed in the provided studies.

Evidence Limitations

The evidence lacks direct studies on the Phoenix Atherectomy Catheter, with existing literature focusing on imaging techniques. Further research is needed to evaluate device-specific outcomes and safety.

Linked Studies (8)

PubMed • 2024

Multicenter comparison of Etest, Vitek2 and BD Phoenix to broth microdilution for beta-lactam susceptibility testing of Streptococcus pneumonia.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Safety and effectiveness of the Phoenix atherectomy device for endovascular treatment of common femoral and popliteal arteries: Results of the EN-MOBILE trial.

Vascular medicine (London, England)

View Source →
PubMed • 2023

Crossing complex infrapopliteal lesions utilizing a front-end cutting technique: A report of two cases with a novel rotational atherectomy device.

SAGE open medical case reports

View Source →
PubMed • 2022

Acute Real-World Outcomes From the Phoenix Post-Approval Registry.

The Journal of invasive cardiology

Other View Source →
PubMed • 2022

Phoenix atherectomy for patients with peripheral artery disease.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2020

A Single-Center Experience With Phoenix Atherectomy System in Patients With Moderate to Heavily Calcified Femoropopliteal Lesions.

Cardiovascular revascularization medicine : including molecular interventions

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2019

Hybrid atherectomy for lower extremity peripheral arterial disease.

Vascular

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2017

Safety and effectiveness of the Phoenix Atherectomy System in lower extremity arteries: Early and midterm outcomes from the prospective multicenter EASE study.

Vascular

View Source →

Frequently Asked Questions

What are the clinical indications for Phoenix Atherectomy Catheter?

The device is indicated for use in atherectomy procedures to remove plaque from blood vessels, particularly in patients with peripheral artery disease.

What outcomes have been reported in clinical studies?

The studies provided focus on imaging techniques rather than direct outcomes of the Phoenix Atherectomy Catheter.

What complications have been reported?

The provided evidence does not detail specific complications for the Phoenix Atherectomy Catheter, focusing instead on imaging-related risks.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.